Study of anti-inflammatory effect of rebamipide eye drops for ocular surface inflammatory diseases

Study of anti-inflammatory effect of rebamipide eye drops for ocular surface inflammatory diseases - Study of anti-inflammatory effect of rebamipide eye drops

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009677

Enrollment

180

Registered

2013-01-01

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Surface inflammatory diseases with dry eye (allergic conjuncivitis, vernal conjunctivitis, Stevens-Johnson syndrome, etc)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ocular surface disease patients with dry eye such as allergic conjunctivitis, vernal conjunctivitis, Stevens-Johnson syndrome, etc.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
finding about ocular surface inflammation such as conjunctival hyperemia and conjunctival papilla formation, etc.	—

Secondary

Measure	Time frame
tear cytokine etc	—

Countries

Japan

Contacts

Public ContactMayumi Ueta

Kyoto Prefectural University of Medicine Department of Ophthalmology

mueta@koto.kpu-m.ac.jp

Outcome results